Premier to Offer Bioventus Surgical Orthobiologics Products to Members

By Julie A. Vetalice

Premier is now offering Bioventus' full surgical orthobiologics product portfolio to its U.S. membership, comprising 3,750 hospitals and >130,000 provider organizations.

The products, used for bone healing and spinal fusion applications, include:

  • OSTEOAMP® allograft, available through Premier since 2012
  • CELLXTRACT® and EXTRACTOR™ autologous cell and marrow extraction devices
  • EXPONENT™ demineralized bone matrix
  • INTERFACE bioactive bone graft
  • OSTEOMATRIX® biphasic mineral/collagen bone graft
  • OSTEOPLUS® biphasic mineral bone graft
  • PUREBONE® demineralized cancellous bone and cancellous chips
  • SIGNAFUSE™ bioactive bone graft substitute

Source: Bioventus LLC

Product Labels: Bone Graft Materials/DBM, Synthetic Bone Graft

Tags: M&A